Local Treatment With Radical Prostatectomy (RP) for Newly-diagnosed Metastatic Prostate Cancer (mPCa).

Condition: Prostatic Neoplasms, Neoplasm Metastasis

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT02138721

Sponsor: University Hospital, Ghent


  • Age: minimum 18 Years maximum 85 Years
  • Gender: Male

Inclusion Criteria:

  • Diagnosis of prostate adenocarcinoma, confirmed by histology
  • Newly diagnosis of metastatic disease (stage TanyNanyM+)
  • Life expectancy ≥2y based on comorbid conditions, WHO performance status 0-2
  • Written informed consent, male ≥18yo
  • Willing and expected to comply with study protocol and follow-up schedule
  • Multidisciplinary Oncologic Consultation (MOC) approval

Exclusion Criteria:

  • Previous local or systemic treatment for prostate cancer
  • Metastatic brain disease, leptomeningeal disease or imminent spinal cord compression
  • Symptoms clearly related to metastatic lesions
  • Any other previous or current (malignant) disease which, in the judgment of the responsible physician, is likely to interfere with LoMP treatment or assessment

View trial on ClinicalTrials.gov